beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Term ID

CHEBI:61864

Synonyms

(GalNAc)1 (GlcNAc)1 (LFuc)1
2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-(acetylamino)-2-deoxy-D-glucopyranose
2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
Fucosylated lacdiNAc
GalNAc(beta1-4)[Fuc(alpha1-3)]GlcNAc
LDN-F

Definition

An amino trisaccharide comprising an acetamido-β-D-galactose and an α-L-fucose attached to an acetamidoglucose by 1→4 and 1→3 linkages, respectively.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype where environments contain beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype modified by environments containing beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Phenotype affecting beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc

Human Disease Model